Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate
出版年份 2018 全文链接
标题
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate
作者
关键词
-
出版物
CHEMISTRY-A EUROPEAN JOURNAL
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-11-20
DOI
10.1002/chem.201805447
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting
- (2018) Lizeth Bodero et al. Beilstein Journal of Organic Chemistry
- Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2
- (2018) Samuele Cazzamalli et al. CLINICAL CANCER RESEARCH
- Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and αV β3 -Integrin Ligands for Tumor Targeting
- (2018) Paula López Rivas et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to αvβ3 without Promoting Integrin Allosteric Activation
- (2018) Francesca Nardelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemically Defined Antibody– and Small Molecule–Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis
- (2018) Samuele Cazzamalli et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Neutrophil elastase in the tumor microenvironment
- (2018) Irina Lerman et al. STEROIDS
- Advances in targeting the folate receptor in the treatment/imaging of cancers
- (2018) Marcos Fernández et al. Chemical Science
- Cancer-targeted delivery systems based on peptides
- (2018) Theodora Chatzisideri et al. Future Medicinal Chemistry
- Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
- (2018) Hirobumi Fuchigami et al. Scientific Reports
- Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy
- (2017) Nicolas Joubert et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma
- (2017) Samuele Cazzamalli et al. JOURNAL OF CONTROLLED RELEASE
- A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo
- (2017) Alberto Dal Corso et al. JOURNAL OF CONTROLLED RELEASE
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers
- (2017) Brigitte Renoux et al. Chemical Science
- Targeting Integrin αV β3 with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario
- (2017) Arianna Pina et al. ChemistrySelect
- Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
- (2017) Alessandra Tolomelli et al. Cancers
- Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models
- (2016) F. Li et al. CANCER RESEARCH
- Development of BT1718, a Bicycle Drug Conjugate® (BDC) targeting MT1-MMP for treatment of solid tumours
- (2016) G. Bennett et al. EUROPEAN JOURNAL OF CANCER
- Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix
- (2016) Rémy Gébleux et al. INTERNATIONAL JOURNAL OF CANCER
- Synthesis of Novel c(AmpRGD)–Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis
- (2016) Andrea Sartori et al. JOURNAL OF MEDICINAL CHEMISTRY
- Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma
- (2016) Samuele Cazzamalli et al. MOLECULAR CANCER THERAPEUTICS
- Antibody-drug conjugates: Current status and future perspectives
- (2016) Rémy Gébleux et al. PHARMACOLOGY & THERAPEUTICS
- CyclicisoDGR and RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds are Integrin Antagonists
- (2015) Silvia Panzeri et al. CHEMISTRY-A EUROPEAN JOURNAL
- Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers
- (2015) Alberto Dal Corso et al. CHEMISTRY-A EUROPEAN JOURNAL
- ?v?3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology
- (2015) Alberto Dal Corso et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Theranostic Vitamin–Linker–Taxoid Conjugates
- (2015) Jacob G. Vineberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- DUPA Conjugation of a Cytotoxic Indenoisoquinoline Topoisomerase I Inhibitor for Selective Prostate Cancer Cell Targeting
- (2015) Jyoti Roy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates
- (2015) R. Gebleux et al. MOLECULAR CANCER THERAPEUTICS
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents
- (2015) Madduri Srinivasarao et al. NATURE REVIEWS DRUG DISCOVERY
- A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
- (2014) Nikolaus Krall et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Curative Properties of Noninternalizing Antibody-Drug Conjugates Based on Maytansinoids
- (2014) E. Perrino et al. CANCER RESEARCH
- Small Targeted Cytotoxics: Current State and Promises from DNA-Encoded Chemical Libraries
- (2013) Nikolaus Krall et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Conjugates of Modified Cryptophycins and RGD-Peptides Enter Target Cells by Endocytosis
- (2013) Markus Nahrwold et al. JOURNAL OF MEDICINAL CHEMISTRY
- The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy
- (2012) Thibaut Legigan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting the Estrogen Receptor using Steroid–Therapeutic Drug Conjugates (Hybrids)
- (2012) Kinh-Luan Dao et al. BIOCONJUGATE CHEMISTRY
- Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands
- (2012) Mattia Marchini et al. CHEMISTRY-A EUROPEAN JOURNAL
- Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine–Glycine–Aspartate (RGD) Peptidomimetic–Paclitaxel Conjugates Targeting Integrin αVβ3
- (2012) Raffaele Colombo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Direct Fluorescence Monitoring of the Delivery and Cellular Uptake of a Cancer-Targeted RGD Peptide-Appended Naphthalimide Theragnostic Prodrug
- (2012) Min Hee Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy
- (2011) Gonçalo J. L. Bernardes et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cancer-Stroma Targeting Therapy by Cytotoxic Immunoconjugate Bound to the Collagen 4 Network in the Tumor Tissue
- (2011) Masahiro Yasunaga et al. BIOCONJUGATE CHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen
- (2011) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Antibody drug-conjugates targeting the tumor vasculature
- (2010) Hans-Peter Gerber et al. mAbs
- Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand
- (2009) Sumith A. Kularatne et al. MOLECULAR PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started